Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsAjantapharma

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to
    • Invest in private sector banks for long-term, says Dipan Mehta

      Invest in private sector banks for long-term, says Dipan Mehta

      In an interview to CNBC-TV18, Dipan Mehta, Member of BSE & NSE shared his readings and outlook on specific stocks and sector.

    • Buy Reliance Capital, Ajanta Pharma, Simplex Infra: Gujral

      Buy Reliance Capital, Ajanta Pharma, Simplex Infra: Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying Reliance Capital, Ajanta Pharma and Simplex Infra.

    • Sell Ajanta Pharma, Ceat: buy Bata India: Sudarshan Sukhani

      Sell Ajanta Pharma, Ceat: buy Bata India: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can sell Ajanta Pharma and Ceat while one can buy Bata India.

    • Buy Torrent Power, IGL, Bata, HUL; avoid Asian Paints: Sukhani

      Buy Torrent Power, IGL, Bata, HUL; avoid Asian Paints: Sukhani

      Sudarshan Sukhani of s2analytics.com suggests buying Torrent Power, Indraprastha Gas, Bata India and Hindustan Unilever and feels that one may avoid Asian Paints and Ajanta Pharma.

    • Top buzzing stocks to trade on January 12

      Top buzzing stocks to trade on January 12

      Here are a few top buzzing stocks picked by CNBC-TV18's analysts in trade today -- Idea Cellular, Sun Pharma, DRL, Lupin, Aurobindo Pharma , Glenmark, Natco Pharma, Alkem Labs, Ajanta Pharma, Strides Shasun, Biocon, Cipla, Cyient, MMTC and Power Grid.

    • Buy Titan, RIL, India Cements; short Ajanta Pharma: Sukhani

      Buy Titan, RIL, India Cements; short Ajanta Pharma: Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can buy Titan Company, Reliance Industries and India Cements and short Ajanta Pharma.

    • Buy Engineers India, PFC; sell Ajanta Pharma: Ashwani Gujral

      Buy Engineers India, PFC; sell Ajanta Pharma: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one may buy Engineers India and Power Finance Corporation and sell Ajanta Pharma.

    • Sell Ajanta Pharma, UltraTech; buy J Kumar Infra, TNPL: Thacker

      Sell Ajanta Pharma, UltraTech; buy J Kumar Infra, TNPL: Thacker

      Mitesh Thacker of miteshthacker.com is of the view that one can sell Ajanta Pharma, JSW Steel and UltraTech Cement and buy J Kumar Infra and Tamil Nadu Newsprint and Papers.

    • Sell Ajanta Pharma, Pidilite Industries: Mitesh Thacker

      Sell Ajanta Pharma, Pidilite Industries: Mitesh Thacker

      According to Mitesh Thacker of miteshthacker.com, one can sell Ajanta Pharma and Pidilite Industries.

    • Short Just Dial; buy Ajanta Pharma: Sudarshan Sukhani

      Short Just Dial; buy Ajanta Pharma: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that one can short Just Dial and buy Ajanta Pharma.

    • Sell Asian Paints, BPCL; buy Ajanta Pharma: Ashwani Gujral

      Sell Asian Paints, BPCL; buy Ajanta Pharma: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one can sell Asian Paints and BPCL and buy Ajanta Pharma.

    • Ajanta Pharma can climb to Rs 1810, Bajaj Auto Rs 2640: Gaba

      Ajanta Pharma can climb to Rs 1810, Bajaj Auto Rs 2640: Gaba

      Prakash Gaba of prakashgaba.com is of the view that Ajanta Pharma can climb to Rs 1810 while Bajaj Auto can test Rs 2640.

    • Ajanta Pharma, Allahabad Bank look weak: Prakash Gaba

      Ajanta Pharma, Allahabad Bank look weak: Prakash Gaba

      According to Prakash Gaba of prakashgaba.com, Ajanta Pharma and Allahabad Bank are looking weak.

    • Buy Petronet LNG; sell Ajanta Pharma, Ambuja Cements: Gujral

      Buy Petronet LNG; sell Ajanta Pharma, Ambuja Cements: Gujral

      Ashwani Gujral of ashwanigujral.com recommends buying Petronet LNG and sell Ajanta Pharma and Ambuja Cements.

    • Sell Ajanta Pharma, Amara Raja; buy Bharat Forge: Mitesh Thacker

      Sell Ajanta Pharma, Amara Raja; buy Bharat Forge: Mitesh Thacker

      Mitesh Thacker of miteshthacker.com is of the view that one can sell Ajanta Pharma and Amara Raja Batteries and buy Bharat Forge.

    • Sell PFC, Britannia, Pidilite, Ajanta Pharma; buy GAIL: Thacker

      Sell PFC, Britannia, Pidilite, Ajanta Pharma; buy GAIL: Thacker

      Mitesh Thacker of miteshthacker.com is of the view that one can sell PFC, Britannia Industries, Pidilite Industries and Ajanta Pharma and buy GAIL India.

    • Bull's Eye: Sell HPCL, CESC, Hindalco, Biocon; buy Hindalco

      Bull's Eye: Sell HPCL, CESC, Hindalco, Biocon; buy Hindalco

      Sumeet Jain of Destimoney Securities is of the view that one may buy Hexaware Technologies with a target of Rs 211.50.

    • Buy M&M, Dabur, Zee Entertainment; sell Ajanta Pharma: Taparia

      Buy M&M, Dabur, Zee Entertainment; sell Ajanta Pharma: Taparia

      Chandan Taparia, Derivative & Technical Analyst at Anand Rathi Securities is of the view that one can buy Mahindra and Mahindra, Dabur India and Zee Entertainment and sell Ajanta Pharma and Syndicate Bank.

    • Sell Ajanta Pharma; buy Container Corporation: Mitesh Thacker

      Sell Ajanta Pharma; buy Container Corporation: Mitesh Thacker

      According to Mitesh Thacker of miteshthacker.com, one can sell Ajanta Pharma and buy Container Corporation.

    • Look at Biocon, Ajanta Pharma can give 25-30% return: Gujral

      Look at Biocon, Ajanta Pharma can give 25-30% return: Gujral

      Ashwani Gujral of ashwanigujral.com is of the view that one can look at Biocon while Ajanta Pharma can give 25-30 percent return.

    • Bull's Eye: Sell Sun TV, Biocon, Oil India, CESC; buy Vedanta

      Bull's Eye: Sell Sun TV, Biocon, Oil India, CESC; buy Vedanta

      Rakesh Bansal of RK Global is of the view that one may sell Biocon with a target of Rs 832.

    • Sell Ajanta Pharma, DHFL; buy HUL: Ashwani Gujral

      Sell Ajanta Pharma, DHFL; buy HUL: Ashwani Gujral

      Ashwani Gujral of ashwanigujral.com recommends selling Ajanta Pharma and DHFL and advises buying Hindustan Unilever.

    • Buy Kotak Mahindra Bank; sell Eicher Motors: Mitesh Thacker

      Buy Kotak Mahindra Bank; sell Eicher Motors: Mitesh Thacker

      Mitesh Thacker of miteshthacker.com advises buying Kotak Mahindra Bank, Ajanta Pharma and suggest selling Eicher Motors.

    • Buy Ajanta Pharma, NCC: Mitesh Thacker

      Buy Ajanta Pharma, NCC: Mitesh Thacker

      Mitesh Thacker of miteshthacker.com recommends buying Ajanta Pharma and NCC.

    • Buy NMDC, Ajanta Pharma; sell Wipro: Sandeep Wagle

      Buy NMDC, Ajanta Pharma; sell Wipro: Sandeep Wagle

      Sandeep Wagle of powermywealth.com is of the view that one can buy NMDC and Ajanta Pharma and sell Wipro.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347